IRIS UniCatt

Albanese, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.252
NA - Nord America 4.758
AS - Asia 2.456
SA - Sud America 508
AF - Africa 45
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.040
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.716
DE - Germania 1.843
CN - Cina 967
SG - Singapore 880
SE - Svezia 819
UA - Ucraina 676
BR - Brasile 468
IT - Italia 394
FR - Francia 390
IE - Irlanda 372
ID - Indonesia 214
GB - Regno Unito 189
RU - Federazione Russa 161
FI - Finlandia 143
IN - India 128
TR - Turchia 99
AT - Austria 67
HK - Hong Kong 36
PL - Polonia 35
NL - Olanda 34
BE - Belgio 28
CI - Costa d'Avorio 25
JP - Giappone 25
CA - Canada 21
VN - Vietnam 17
KR - Corea 15
AR - Argentina 14
ES - Italia 14
BD - Bangladesh 12
MX - Messico 12
AU - Australia 10
IR - Iran 10
BG - Bulgaria 9
GR - Grecia 9
EE - Estonia 8
RO - Romania 8
CZ - Repubblica Ceca 7
EC - Ecuador 7
HU - Ungheria 7
CH - Svizzera 6
IQ - Iraq 6
MA - Marocco 6
PE - Perù 6
PK - Pakistan 6
EU - Europa 5
IL - Israele 5
LT - Lituania 5
MD - Moldavia 5
TW - Taiwan 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
DK - Danimarca 4
EG - Egitto 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BO - Bolivia 3
CO - Colombia 3
HN - Honduras 3
KZ - Kazakistan 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SI - Slovenia 3
TH - Thailandia 3
TN - Tunisia 3
VE - Venezuela 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
CL - Cile 2
KE - Kenya 2
KG - Kirghizistan 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
AL - Albania 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 13.040
Salva come PNG Salva come JPEG
Città #
Chandler 859
Ashburn 561
Singapore 481
Dublin 371
San Mateo 335
Jacksonville 314
Jakarta 212
Nanjing 205
Wilmington 177
Lawrence 115
Dearborn 111
Boston 109
Ann Arbor 105
Moscow 101
Woodbridge 100
Nürnberg 85
Princeton 83
Redwood City 82
Houston 80
Beijing 79
Milan 77
Izmir 75
New York 70
Nanchang 67
Shenyang 66
Lancaster 61
Cattolica 60
Seattle 57
Fairfield 50
Norwalk 49
Mountain View 48
University Park 45
Hefei 43
Bremen 41
Jiaxing 38
Hangzhou 37
Tianjin 37
Hebei 35
Changsha 34
Detroit 34
Marseille 33
Redmond 33
São Paulo 32
Boardman 31
Hong Kong 31
Los Angeles 30
Kunming 29
Rome 29
Brussels 28
Pune 28
Abidjan 25
Chicago 23
Zhengzhou 23
Munich 20
Falls Church 19
Frankfurt am Main 19
Kraków 19
Nuremberg 18
Simi Valley 18
Guangzhou 16
London 16
Ningbo 15
Washington 15
Ypsilanti 15
Leawood 14
Seoul 14
Düsseldorf 13
Fremont 13
Brasília 11
Busto Arsizio 11
Jinan 11
Shanghai 11
Fuzhou 9
Paris 9
Rio de Janeiro 9
Trieste 9
Warsaw 9
Bexley 8
Campinas 8
Edinburgh 8
Hanoi 8
Lanzhou 8
Phoenix 8
San Francisco 8
Belo Horizonte 7
Curitiba 7
Fort Worth 7
Taizhou 7
Vienna 7
Budapest 6
Changchun 6
Costa Mesa 6
Council Bluffs 6
Fortaleza 6
Groningen 6
Millbury 6
Newark 6
Portsmouth 6
Toronto 6
Amsterdam 5
Totale 6.453
Salva come PNG Salva come JPEG
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 332
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 153
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 152
Mutation screening of the DYT6/THAP1 gene in Italy 145
Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 144
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 140
Organization of central nervous system dopaminergic pathways 136
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 135
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 130
Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease 130
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 121
Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease 118
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 116
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 116
Clinical and genetic characteristics of late-onset Huntington's disease 114
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up 110
Analysis of blink rate in patients with blepharospasm 107
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 106
Early DEtection of wEaring off in Parkinson disease: the DEEP study 105
Advances in the genetics of primary torsion dystonia 103
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 101
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 100
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 100
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 99
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 98
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 98
Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation 96
Abnormal gating of somatosensory inputs in essential tremor. 95
Behavioral and personality features in patients with lateralized Parkinson's disease 95
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 95
PINK1 mutations are associated with sporadic early-onset parkinsonism. 93
Phenotypic characterisation of DYT13 primary torsion distonia. 92
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs Dysport" controlled trial. 92
Attentional networks in Parkinson's disease 92
Gastroenterologia. 91
Botulinum toxin injected in the gastric wall reduces body weight and food intake rats. 90
Smooth muscle spasms and sphincters. 89
Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease 87
DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in a Italian family with cranial-cervical or upper limb onset. 86
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes 86
Dystonia rating scales: critique and recommendations 86
Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. 85
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 85
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 84
Primary dystonias 84
A 52-Year-Old Man with Myoclonic Jerks 84
Choice-option evaluation is preserved in early Huntington and Parkinson's disease 83
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. 82
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 82
Isolated limb dystonia as presenting feature of Parkin disease 82
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 81
Management of bladder, prostatic and pelvic floor disorders 81
Dystonia: diagnosis and management 81
EFNS guidelines on diagnosis and treatment of primary dystonias 80
Onset and progression of primary torsion dystonia in sporadic and familial cases 79
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome 79
Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincter spasms. 78
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 78
Phenomenology and classification of dystonia: a consensus update 75
Aging is associated with a diffuse impairment of forebrain cholinergic neurons 74
Primary focal hyperhidrosis in a new family not linked to known loci 73
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders 73
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36 72
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease 72
Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions 72
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 72
Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease. 71
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease 71
Dystonic tremor 71
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 70
Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists. 69
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 69
Correlation of cardiovascular autonomic function tests, magnetic resonance brain imaging and clinical features in suspect cases of multiple system atrophy 69
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 69
Isolated cervical dystonia: diagnosis and classification 68
Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study 68
Effectiveness of higher doses of botulinum toxin to induce healing in patients eith chronic anal fissure. 67
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement 67
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 66
Dystonia and tremor: the clinical syndromes with isolated tremor 66
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 66
Subthalamic involvement in monetary reward and its dysfunction in parkinsonian gamblers 65
Design and Operation of the Lombardy Parkinson's Disease Network 65
Age-dependent loss of cholinergic neurones in basal ganglia of rats 64
The natural history of multiple system atrophy: a prospective European cohort study 64
Quantitative gait analysis in parkin disease: Possible role of dystonia 64
Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. 63
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia. 62
Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode 61
Therapeutic advances in dystonia 61
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 61
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 60
Reliability and validity of the range of motion scale (ROMS) in patients with abnormal postures 60
Pallidal stimulation for acquired dystonia due to cerebral palsy: Beyond 5 years 59
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin 58
Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts 58
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation:De novo cases and 3-year follow-up 58
Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy 58
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial 58
Deep brain stimulation for Parkinson's disease: where do we stand? 57
Totale 8.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 0 0 0 0 0 0 148
2020/20211.268 43 164 26 149 165 47 184 20 177 58 213 22
2021/20221.327 188 152 22 44 46 31 20 271 48 59 206 240
2022/20232.533 348 339 229 350 226 300 96 173 324 30 89 29
2023/20241.529 47 487 41 239 42 139 81 43 21 55 160 174
2024/20252.281 64 90 259 56 176 84 79 105 539 215 561 53
Totale 13.206